Hangzhou First People's Hospital
Hangzhou, Zhejiang, 310006, China
NCT Number: NCT05475782
Overall stone clearance with endoscopic retrograde cholangiopancreatography (ERCP) for pancreatic duct stones is a amjor problem, especially bigger size stones. After ERCP failure, surgery was the only option but patients not suitable for surgery were treated through stenting. But had to undergo multiple ERCPs and show lower success rate. Recently, SpyGlass and extracorporeal shock wave lithotripsy (ESWL) have been applied for the treatment of huge stones. The present study aims to compare the efficacy and safety outcomes of SpyGlass-guided lithotripsy and ESWL procedures for the removal of pancreatic duct stones.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Hangzhou, Zhejiang, 310006, China
ESWL was first used for the removal of renal calculi and ureteral calculi however, now a day is being used for pancreatic duct stones and biliary calculi. It has the advantages of simple operation, lower cost, and higher safety. Recent studies show that the procedure time for ESWL is also shorter and the utilization rate of mechanical lithotripsy was effectively reduced with fewer complications. But It is difficult for ESWL to break the stones larger than 3cm into small pieces.
Spyglass has been used in clinics for more than ten years. Recently, a study reported difficult bile duct stones that were treated with SpyGlass-guided laser lithotripsy that shows promising results. Compared with laser lithotripsy under X-ray monitoring, there is no significant difference in stone removal rate and complication rate between the two methods. However, the effect of lithotripsy under Spyglass direct vision is better, which can break large stones into smaller pieces, thus making it easier to take stones. Investigator conducted the current study to compare the therapeutic outcome and complications between SpyGlass direct vision lithotripsy and ESWL procedures for the removal of large pancreatic duct stones.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Spyglass-guided lithotripsy
Other names: Direct vision system
ESWL+ERCP
Other names: Lithotripsy through ESWL
Time frame: Intraoperative
Successfull intervention
Time frame: 1 month
Pancreatic duct stone clearance rate
Time frame: 1 month
procedure related adverse events, bleeding, pancreatitis, etc
Time frame: 1 month
Number of ERCPs performed for stone clearnce
Time frame: 1 month
Total sessions of therapy
First People's Hospital of Hangzhou
Other
Spyglass-guided Lithotripsy Vs ESWL for Pancreatic Duct Stones
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05289362
Chronic Disease, Digestive System Diseases
Shanghai, China
View Trial DetailsNCT04232670
Pancreatic Duct Dilatation, Pancreatic Duct Stone
Portland, Oregon, United States
View Trial DetailsNCT04158297
Chronic Disease, Chronic Pancreatitis
Indianapolis, Indiana, United States
View Trial DetailsNCT05669573
Behavior, ESWL
Shanghai, China
View Trial Details